JUVE Patent

Anja has experience in worldwide patent portfolio strategy and management, including drafting and prosecuting patent applications, as well as defending and challenging patent rights in all areas of biochemistry and chemistry, biotechnology, and pharmaceuticals, including antibodies, small molecules, antibody-drug-conjugates, T cell receptors, personalized medicine, vaccines, gene therapy, as well as pharmaceutical formulations. She is also involved in the preparation of opinions on freedom-to-operate, infringement, and validity questions.

After having passed the German patent attorney examination and the European qualifying examination in February and March 2023, Anja worked at the US law firm Sterne, Kessler, Goldstein & Fox in Washington, D.C., from May to December 2023. During her stay at Sterne Kessler, Anja was inter alia involved in preparing the patent defense in post grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the USPTO, preparation of validity opinions, freedom-to-operate and patentability analysis, as well as drafting patent applications. She also gained insights into inter partes review (IPR) proceedings before the PTAB and appeal proceedings before the U.S. Court of Appeals for the Federal Circuit (CAFC). In September 2023, Anja passed the US patent bar examination to complement her German and European qualifications.

During her time in the US, Anja gained a fundamental understanding of US patent law, which supplements her knowledge of European and German patent law. This allows her to advice clients on European and German patent matters in a global context, enabling her to build bridges between important jurisdictions for an optimum worldwide strategy.

Anja received her bachelor’s and master’s degrees in biochemistry, as well as her PhD from the Technical University of Munich. Her PhD focused on all aspects of mass spectrometry-based proteomics, including bacterial and mammalian cell culture, as well as the statistical evaluation of mass spectrometric data.